前沿生物：关于向2025年限制性股票激励计划激励对象授予预留限制性股票的公告

Core Viewpoint - Frontier Biopharmaceuticals announced the successful achievement of the granting conditions for its 2025 restricted stock incentive plan, allowing the company to proceed with the allocation of restricted stocks to selected incentive targets [1] Group 1 - The company held its fourth board meeting on December 11, 2025, where it approved the proposal to grant reserved restricted stocks under the 2025 incentive plan [1] - A total of 750,000 restricted stocks will be granted at a price of 8.56 yuan per share to four incentive targets [1] - The granting date for the restricted stocks is set for December 11, 2025, following the authorization from the company's second extraordinary general meeting of shareholders in 2025 [1]